Minimal Residual Disease Detection in Pediatric Acute Lymphoblastic Leukemia
Minimal residual disease (MRD) status is the strongest independent prognostic factor for patients with pediatric acute lymphoblastic leukemia (ALL). Monitoring of the MRD status allows risk-adapted therapy as its absence or presence guides patient therapy and can result in significant treatment redu...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
The Korean Society of Pediatric Hematology-Oncology
2020-10-01
|
| Seria: | Clinical Pediatric Hematology-Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.15264/cpho.2020.27.2.87 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|